Company intelligence / Profile preview

OMSCAN

Ramat Gan, Israel
Ownership
Private
Development stage
Other
01

Overview

Omscan was an Israeli medical technology company that developed a proprietary system for the real-time, non-invasive monitoring of microcirculation and tissue metabolism. The company's core technology, based on the work of Professor Avraham Mayevsky, utilized multi-parametric sensors to assess tissue vitality by measuring parameters such as mitochondrial function (NADH fluorescence), blood flow (Laser Doppler), and oxygenation. Designed primarily for use in critical care and surgical settings, the Omscan device aimed to provide clinicians with early warnings of tissue ischemia or metabolic distress. While the technology showed significant promise in clinical research, the company is no longer active in its original form.

Therapeutic areas
CardiovascularOther
Modalities
Device
Industry
Physiological Monitoring
02

Partnerships

Hutchison Bio-Pharma

Beyond the preview

Go deeper on OMSCAN.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMSCAN.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call